News

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
You wouldn’t think you could live when both your heart and lungs are failing, but there is technology that makes it possible.
At the 35th annual Extracorporeal Life Support Services (ELSO) conference, Rhode Island and Hasbro Children's Hospitals were ...
Each year, an estimated 150,000 people in the United States are hospitalized due to pneumococcal pneumonia, the most common form of bacterial pneumonia.
A large cohort study from China and the U.S. shows that Circadian Syndrome (CircS)—a cluster of metabolic and behavioral ...
A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...
After undergoing foot surgery for a collegiate sports injury, Hannah Burton knew something was wrong. In the middle of the night, her family realized she was unresponsive and called emergency ...
An innovative, minimally invasive procedure is reducing the risk faced by patients with heart valve disease and improving ...
The terms comfort care and hospice are sometimes used interchangeably, even among healthcare providers. Learn why definitions ...
Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...
So, what would happen without Medicaid? My patients will be forced to forgo lifesaving care, and they will die.
Extracorporeal membrane oxygenation (ECMO) is an advanced life-support technique used for patients with severe heart or lung failure. It functions by circulating blood outside the body through a ...